Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.04. | Gemina Laboratories Ltd: Gemina licenses biosensing architecture from UBC | 1 | Stockwatch | ||
09.04. | Gemina Laboratories Ltd.: Gemina Labs Announces Addition to its IP Portfolio | 117 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE /April 9, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") today announces that it has licensed a novel biosensing architecture from the University... ► Artikel lesen | |
02.04. | Gemina Laboratories Ltd: Gemina Laboratories signs licensing deal | 1 | Stockwatch | ||
02.04. | Gemina Laboratories Ltd.: Gemina Laboratories Sign First Strategic License Agreement | 196 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / April 2, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the signing of a license agreement with a significant global... ► Artikel lesen | |
21.03. | Gemina Laboratories Ltd: Gemina Laboratories to focus on respiratory infections | 1 | Stockwatch | ||
21.03. | Gemina Laboratories Ltd.: Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships | 210 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / March 21, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide a strategic update and outlook for 2024 and beyond. The Company... ► Artikel lesen | |
19.03. | Gemina Laboratories Ltd: Gemina Laboratories closes $910,000 note financing | 1 | Stockwatch | ||
19.03. | Gemina Laboratories Ltd.: Gemina Announces Closing of $910,000 Convertible Note Financing | 219 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / March 19, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that further to its news release dated February 22, 2024... ► Artikel lesen | |
23.02. | Gemina Laboratories Ltd: Gemina Laboratories arranges $1-million note financing | 2 | Stockwatch | ||
29.12.23 | Gemina Laboratories Ltd: Gemina's Porter resigns as director, president | 2 | Stockwatch | ||
06.11.23 | Gemina Laboratories Ltd: Gemina Laboratories hires Stifel as financial adviser | 1 | Stockwatch | ||
06.11.23 | Gemina Laboratories Ltd.: Gemina Labs Ltd Appoints Stifel as Financial Advisor | 280 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / November 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7), a diagnostics technology company, is pleased to announce that it has appointed the global investment bank... ► Artikel lesen | |
25.07.23 | Gemina Laboratories Ltd.: Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose | 308 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / July 25, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is excited to announce another major innovation in lateral flow assay ("LFA") test... ► Artikel lesen | |
15.06.23 | Gemina Laboratories Ltd.: Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting | 386 | ACCESSWIRE | Gemina to present achievement of another significant technical milestone.VANCOUVER, BC / ACCESSWIRE / June 15, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7), a specialist in fast, affordable,... ► Artikel lesen | |
05.06.23 | Gemina Laboratories Ltd.: Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva | 707 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / June 5, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7), a specialist in fast, affordable, and accurate diagnostic tests, is delighted to announce significant technical... ► Artikel lesen | |
17.05.23 | Gemina Laboratories Ltd.: Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement | 583 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / May 17, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is delighted to announce that its patented chemistry for Antibody Immobilization... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
FRESENIUS | 27,210 | +0,11 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | AKTIEN IM FOKUS: Positiver Trend von FMC und Fresenius hält an | FRANKFURT (dpa-AFX) - Für die Papiere von Fresenius Medical Care (FMC) und Fresenius setzt sich der jüngste Aufwärtstrend am Montag fort. Die Titel des Medizinkonzerns und Krankenhausbetreibers Fresenius... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
GERRESHEIMER | 100,50 | +1,31 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
LIFEMD | 11,950 | +10,44 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | ||
BRIGHTSPRING HEALTH SERVICES | 10,580 | +1,63 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
ECKERT & ZIEGLER | 36,720 | +1,89 % | EQS-Adhoc: Eckert & Ziegler SE: Eckert & Ziegler in Q1 mit deutlichem Anstieg bei Umsatz und Ergebnis gegenüber Vorjahr. Jahresprognose 2024 bestätigt. | EQS-Ad-hoc: Eckert & Ziegler SE / Schlagwort(e): Quartalsergebnis/Vorläufiges Ergebnis
Eckert & Ziegler in Q1 mit deutlichem Anstieg bei Umsatz und Ergebnis gegenüber Vorjahr. Jahresprognose... ► Artikel lesen | |
GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen |